Revolutionizing CGM Accessibility and Performance Trinity Biotech’s redesigned ergonomic modular CGM system is designed with affordability, accuracy, and sustainability in mind. The device’s ...

Trinity Biotech ( (TRIB)) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous glucose monitoring (CGM) system, following its latest pre ...

Trinity Biotech's next-generation CGM system includes reusable and rechargeable components, aiming to make the technology more affordable and environmentally friendly. This development could ...

(MENAFN- GlobeNewsWire - Nasdaq) Trinity Biotech's patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029 DUBLIN, Feb. 06, 2025 (GLOBE ...

To stay updated on Trinity Biotech’s CGM developments, visit https://cgm.trinitybiotech.com. Forward-Looking Statements This release includes statements that constitute “forward-looking ...

Revolutionizing CGM Accessibility and Performance Trinity Biotech's redesigned ergonomic modular CGM system is designed with affordability, accuracy, and sustainability in mind. The device's ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a leader in diabetes management solutions currently trading at $0.86 per share, has announced significant enhancements in the performance of its continuous ...

Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc ...

Revolutionizing CGM Accessibility and Performance Trinity Biotech’s redesigned ergonomic modular CGM system is designed with affordability, accuracy, and sustainability in mind. The device’s reusable ...